Skip to main content

Advertisement

Log in

Usefulness of Automatic Quantification of Immunochemical Staining on Whole Tumor Sections for Correlation with Oncological Small Animal PET Studies: An Example with Cell Proliferation, Glucose Transporter 1 and FDG

  • Brief Article
  • Published:
Molecular Imaging and Biology Aims and scope Submit manuscript

Abstract

Aim

To highlight the use of automatic quantification of immunochemical staining on digitized images of whole tumor sections in preclinical positron emission tomography (PET) studies.

Materials and methods

Xenografted human testicular tumors (36) were imaged with 2-deoxy-2[F-18]fluoro-d-glucose (FDG) small animal PET (SA-PET). Tumor cell proliferation and glucose transportation were assessed with cyclin A and Glut-1 immunostaining. Tumor slides were digitized and processed with PixCyt® software enabling whole slide quantification, then compared with junior and senior pathologist manual scoring. Manual and automatic quantification results were correlated to FDG uptake.

Results

For cyclin A, inter- and intra-observer agreement for manual scoring was 0.52 and 0.72 and concordance between senior pathologist and automatic quantification was 0.84. Correlations between Tumor/Background ratio and tumor cell proliferation assessed by automatic quantification, junior and senior pathologists were 0.75, 0.55, and 0.61, respectively. Correlation between Tumor/Background ratio and Glut-1 assessed by automatic quantification was 0.74.

Conclusion

Automatic quantification of immunostaining is a valuable tool to overcome inter- and intra-observer variability for correlation of cell proliferation or other markers with tumor tracer uptake.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nanni C, Di Leo K, Tonelli R et al (2007) FDG small animal PET permits early detection of malignant cells in a xenograft murine model. Eur J Nucl Med Mol Imaging 34:755–762

    Article  PubMed  Google Scholar 

  2. Aliaga A, Rousseau JA, Cadorette J et al (2007) A small animal positron emission tomography study of the effect of chemotherapy and hormonal therapy on the uptake of 2-deoxy-2-[F-18]fluoro-d-glucose in murine models of breast cancer. Mol Imaging Biol 9:144–150

    Article  PubMed  Google Scholar 

  3. Cullinane C, Dorow DS, Kansara M et al (2005) An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res 65:9633–9636

    Article  PubMed  CAS  Google Scholar 

  4. Dorow DS, Cullinane C, Conus N et al (2006) Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033. Eur J Nucl Med Mol Imaging 33:441–452

    Article  PubMed  Google Scholar 

  5. Nanni C, Rubello D, Khan S, Al Nahhas A, Fanti S (2007) Role of small animal PET in stimulating the development of new radiopharmaceuticals in oncology. Nucl Med Commun 28:427–429

    Article  PubMed  Google Scholar 

  6. Nanni C, Rubello D, Fanti S (2007) Role of small animal PET for molecular imaging in pre-clinical studies. Eur J Nucl Med Mol Imaging 34:1819–1822

    Article  PubMed  Google Scholar 

  7. Molthoff CF, Klabbers BM, Berkhof J et al (2007) Monitoring response to radiotherapy in human squamous cell cancer bearing nude mice: comparison of 2¢-deoxy-2¢-[(18)F]fluoro-d:-glucose (FDG) and 3¢-[(18)F]fluoro-3¢-deoxythymidine (FLT). Mol Imaging Biol 9:340–347

    Article  PubMed  Google Scholar 

  8. Brepoels L, Stroobants S, Vandenberghe P et al (2007) Effect of corticosteroids on 18F-FDG uptake in tumor lesions after chemotherapy. J Nucl Med 48:390–397

    PubMed  CAS  Google Scholar 

  9. Leyton J, Latigo JR, Perumal M, Dhaliwal H, He Q, Aboagye EO (2005) Early detection of tumor response to chemotherapy by 3¢-deoxy-3¢-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo. Cancer Res 65:4202–4210

    Article  PubMed  CAS  Google Scholar 

  10. Huisman MC, Reder S, Weber AW, Ziegler SI, Schwaiger M (2006) Performance evaluation of the Philips MOSAIC small animal PET scanner. Eur J Nucl Med Mol Imaging 34:532–540

    Article  PubMed  Google Scholar 

  11. Chiang S, Cardi C, Matej S et al (2004) Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner. Nucl Med Commun 25:1103–1107

    Article  PubMed  Google Scholar 

  12. Aide N, Louis MH, Dutoit S et al (2007) Improvement of semi-quantitative small-animal PET data with recovery coefficients: a phantom and rat study. Nucl Med Commun 28:813–822

    Article  PubMed  Google Scholar 

  13. Calvet L, Geoerger B, Regairaz M et al (2006) Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan. Oncogene 25:3150–3159

    Article  PubMed  CAS  Google Scholar 

  14. Elie N, Plancoulaine B, Signolle JP, Herlin P (2003) A simple way of quantifying immunostained cell nuclei on the whole histologic section. Cytometry A 56:37–45

    Article  PubMed  Google Scholar 

  15. Elie N, Kaliski A, Peronneau P, Opolon P, Roche A, Lassau N (2007) Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth. Ultrasound Med Biol 33:549–560

    Article  PubMed  Google Scholar 

  16. Galaup A, Cazes A, Le Jan S et al (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci U S A 103:18721–18726

    Article  PubMed  CAS  Google Scholar 

  17. Vesselle H, Schmidt RA, Pugsley JM et al (2000) Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography. Clin Cancer Res 6:3837–3844

    PubMed  CAS  Google Scholar 

  18. Howard CV, Reed MG (1998) Unbiased stereology: three-dimensional measurement in microscopy. BIOS Scientific, London

    Google Scholar 

  19. Riedl CC, Akhurst T, Larson S et al (2007) 18F-FDG PET scanning correlates with tissue markers of poor prognosis and predicts mortality for patients after liver resection for colorectal metastases. J Nucl Med 48:771–775

    Article  PubMed  Google Scholar 

  20. Yamamoto Y, Nishiyama Y, Ishikawa S et al (2007) Correlation of (18)F-FLT and (18)F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer. Eur J Nucl Med Mol Imaging 34:1610–1616

    Article  PubMed  CAS  Google Scholar 

  21. Aide N, Briand M, Dutoit S et al (2007) Early evaluation of chemotherapy effect with longitudinal fluorodeoxyglucose (FDG) small animal PET (SA-PET) in human testicular cancer xenografts. Eur J Nucl Med Mol Imaging 34:S298

    Google Scholar 

  22. Desdouets C, Sobczak-Thepot J, Murphy M, Brechot C (1995) Cyclin A: function and expression during cell proliferation. Prog Cell Cycle Res 1:115–123

    PubMed  CAS  Google Scholar 

  23. Yam CH, Fung TK, Poon RY (2002) Cyclin A in cell cycle control and cancer. Cell Mol Life Sci 59:1317–1326

    Article  PubMed  CAS  Google Scholar 

  24. Ishibashi H, Suzuki T, Suzuki S et al (2005) Progesterone receptor in non-small cell lung cancer—a potent prognostic factor and possible target for endocrine therapy. Cancer Res 65:6450–6458

    Article  PubMed  CAS  Google Scholar 

  25. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Edwige Deslandes for cell line management, Mélanie Briand for her help during small animal PET acquisitions, Natacha Heutte for the statistical studies and Mylene Brécin for her help during whole slide scanning. Heather Costil is thanked for manuscript editing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicolas Aide.

Additional information

This work was supported by a grant from the French Ligue Contre le Cancer, Comité du Calvados. Alexandre Labiche received a fellowship from the Ligue Contre le Cancer, Comité de la Manche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aide, N., Labiche, A., Herlin, P. et al. Usefulness of Automatic Quantification of Immunochemical Staining on Whole Tumor Sections for Correlation with Oncological Small Animal PET Studies: An Example with Cell Proliferation, Glucose Transporter 1 and FDG. Mol Imaging Biol 10, 237–244 (2008). https://doi.org/10.1007/s11307-008-0144-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11307-008-0144-5

Key words

Navigation